Inovio Pharmaceuticals (INO) Competitor Comparison
We are evaluating the key criteria listed to compare Inovio Pharmaceuticals (INO) against its competitors in the Biotechnology industry.
Market Capitalization
224 / 368Gross Profits
261 / 278Total Revenue
240 / 300EBITDA
257 / 337Free Cashflow
289 / 352Quick Ratio
226 / 357Earnings per Share
301 / 359Dividend yield
0 / 6Total Cash
176 / 358Performance 3 years
317 / 368Performance 5 years
241 / 368Performance 10 years
296 / 368Linearity 3 years
288 / 368Linearity 5 years
60 / 368Linearity 10 years
181 / 368Total Rank
160 / 368Dividend Rank
164 / 368Valuation Rank
129 / 368Piotroski Rank
188 / 368Muliplier Rank
27 / 368Performance 5 years - INO ranking 241 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.